Clinical Roundup Ibrance + standard-of-care extends median PFS by over 15 months in HR+, HER2+ metastatic breast cancer, phase III trial shows January 10, 2025Vol.51 No.01
Clinical Roundup Rybrevant + Lazcluze show improvement in OS versus osimertinib January 10, 2025Vol.51 No.01
Clinical Roundup Elinzanetant meets all endpoints in phase III trial for vasomotor symptoms caused by breast cancer treatments January 10, 2025Vol.51 No.01
Clinical Roundup A low omega-6, omega-3 rich diet + fish oil may slow prostate cancer growth, UCLA phase III trial finds January 10, 2025Vol.51 No.01
Clinical Roundup UCLA: Advanced imaging uncovers hidden metastases in high-risk prostate cancer cases January 10, 2025Vol.51 No.01
Clinical Roundup Researchers develop system which helps overcome CAR T-cell resistance in preclinical models January 10, 2025Vol.51 No.01
Clinical Roundup Physicians with the Lymphoma Research Foundation present research focused on immunotherapy, disparities at ASH 2024 January 10, 2025Vol.51 No.01
Clinical Roundup Psychedelic drug therapy may address mental health concerns in people with cancer and addiction January 10, 2025Vol.51 No.01
Clinical Roundup Hair growth drug safe at low doses for breast cancer patients, retrospective cohort study shows January 10, 2025Vol.51 No.01
Clinical Roundup UTSW scientists link hematopoietic cell transplant deaths to beta-blocker use January 10, 2025Vol.51 No.01
